ALIGNMENT HEALTHCARE INC ALHC
ASignal's systematic analysis rates ALHC as Neutral.
Reflects the latest available analysis · analyzed Nov 4, 2026
The case on ALHC
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- RSI indicates oversold condition (25.69)
- Strong revenue growth (36.7% YoY)
- High growth score (0.9)
- Free cash flow positive ($77.02M)
- EV/Revenue low at 0.23x suggesting potential undervaluation
- Negative operating margin (-0.28%)
- High debt-to-equity ratio (1.19x)
- Low net profit margin (0.58%)
- No Reddit mentions indicating low retail interest
- Limited news coverage from only two sources
- Forward P/E (13.32x) not exceptionally low for healthcare sector
See the full verdict on ALHC
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes ALHC
Most investors never get a second opinion, let alone several. ASignal runs ALHC past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.